$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Can I stop taking Upadacitinib once every seven days?
2026-02-01 22:25:32
Check Details
Upadacitinib discontinuation outbreak
2026-02-01 22:25:32
Check Details
Will eczema go away after taking Upadacitinib?
2026-02-01 22:25:32
Check Details
Are there any serious side effects of Upadacitinib?
2026-02-01 22:25:32
Check Details
Price of Upadacitinib
2026-02-01 22:25:32
Check Details
Which country is Upadacitinib available in?
2026-02-01 22:25:32
Check Details
How long does a course of Upadacitinib last?
2026-02-01 22:25:32
Check Details
Can Alpelisib treat lung adenocarcinoma?
2026-02-01 22:25:32
Check Details
Can Alpelisib treat hemangiomas?
2026-02-01 22:25:32
Check Details
How effective is Alpelisib?
2026-02-01 22:25:32
Check Details
How much does Alpelisib cost?
2026-02-01 22:25:32
Check Details
How much does Alpelisib cost after medical insurance?
2026-02-01 22:25:32
Check Details
1
2
...
368
369
370
371
372
373
374
...
10222
10223
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
2
FDA Approves Subcutaneous Isatuximab (Sarclisa) for Multiple Myeloma: A New Administration Option
3
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
4
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
5
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
6
Vadadustat: Clinical Evidence and Patient Benefits of an Oral HIF-PHI for CKD-Related Anemia
7
Ponatinib vs. Olverembatinib: A Multidimensional Comparison of Third-Generation BCR-ABL Inhibitors
8
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
9
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
10
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
11
Avatrombopag (Doptelet): Oral TPO-RA for Multiple Thrombocytopenia Types
12
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer